Pasithea Therapeutics Corp.
KTTA
$0.7174
$0.00030.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.88% | 7.71% | 37.05% | 16.96% | -2.74% |
| Total Depreciation and Amortization | -0.37% | -0.37% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.53% | -90.78% | 124.79% | -67.23% | 201.65% |
| Change in Net Operating Assets | 28.43% | 133.57% | -68.64% | -485.76% | -268.70% |
| Cash from Operations | 4.21% | 29.28% | 37.45% | -17.55% | -16.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 217.65% | -- |
| Foreign Exchange rate Adjustments | 293.10% | -- | 806.45% | -530.23% | -866.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.41% | 63.41% | 25.06% | 119.73% | -23.74% |